HKIM
TEVA icon

Hayek Kallen Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Hayek Kallen Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-64,482
Closed -$2.14M – 68
2017
Q2 		$2.14M Sell
64,482
-1,019
-2% -$31.5K 1.45% 32
2017
Q1 		$2.1M Sell
65,501
-938
-1% -$32K 1.46% 31
2016
Q4 		$2.41M Sell
66,439
-5,428
-8% -$217K 1.75% 28
2016
Q3 		$3.31M Buy
71,867
+1,381
+2% +$72.1K 2.36% 19
2016
Q2 		$3.54M Buy
70,486
+3,251
+5% +$173K 2.54% 19
2016
Q1 		$3.6M Sell
67,235
-399
-0.6% -$23.4K 2.67% 16
2015
Q4 		$4.44M Sell
67,634
-1,749
-3% -$108K 3.4% 10
2015
Q3 		$3.92M Sell
69,383
-5,729
-8% -$371K 3.05% 13
2015
Q2 		$4.44M Buy
75,112
+681
+0.9% +$42K 3.32% 10
2015
Q1 		$4.64M Sell
74,431
-1,260
-2% -$73.3K 3.42% 10
2014
Q4 		$4.35M Sell
75,691
-2,135
-3% -$119K 3.22% 13
2014
Q3 		$4.18M Sell
77,826
-1,250
-2% -$66.2K 3.18% 13
2014
Q2 		$4.14M Sell
79,076
-1,148
-1% -$58.7K 3.13% 13
2014
Q1 		$4.24M Sell
80,224
-2,147
-3% -$99.2K 3.38% 10
2013
Q4 		$3.3M Sell
82,371
-1,748
-2% -$68.8K 2.57% 19
2013
Q3 		$3.18M Sell
84,119
-4,022
-5% -$157K 2.63% 17
2013
Q2 		$3.46M Buy
+88,141
New +$3.43M 2.92% 14

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Hayek Kallen Investment Management's TEVA Position: Q3 2017 in Review

Hayek Kallen Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 64,482 shares — an estimated $2.14M sold.

Hayek Kallen Investment Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $4.64M in Q1 2015. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Hayek Kallen Investment Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Hayek Kallen Investment Management sold 64,482 Teva Pharmaceuticals shares in Q3 2017, an estimated $2.14M.
  • Hayek Kallen Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Hayek Kallen Investment Management's Teva Pharmaceuticals position peaked at $4.64M in Q1 2015.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Hayek Kallen Investment Management's 13F filing for Q3 2017, filed 25 Oct 2017.